CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Perdagangan Monopar Therapeutics Inc. - MNPR CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024874%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.002651%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 1.35-4.88
Average Volume (10 days) 91.87K
Average Volume (3 months) 732.34K
Market Cap 19.53M
P/E Ratio -100.00K
Shares Outstanding 13.19M
Revenue N/A
EPS -0.83
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date May 10, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Monopar Therapeutics Inc. Events

Time (UTC) Country Event
Monday, April 3, 2023

Time (UTC)

17:00

Country

US

Event

Monopar Therapeutics Inc at Jefferies Radiopharma Innovation Summit
Monopar Therapeutics Inc at Jefferies Radiopharma Innovation Summit

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Revenue 0 0
Total Operating Expense 10.5369 9.12725 6.50888 4.32376 3.33115
Selling/General/Admin. Expenses, Total 2.94528 2.63404 2.44368 2.35524 1.55669
Research & Development 7.5916 6.49321 4.0652 1.96852 1.77445
Operating Income -10.5369 -9.12725 -6.50888 -4.32376 -3.33115
Interest Income (Expense), Net Non-Operating 0.02124 0.02402 0.0819 0.09889 0.10322
Net Income Before Taxes -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Net Income After Taxes -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Net Income Before Extra. Items -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Net Income -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Income Available to Common Excl. Extra. Items -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Income Available to Common Incl. Extra. Items -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Diluted Net Income -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
Diluted Weighted Average Shares 12.7182 12.4722 10.9583 10.421 10.421
Diluted EPS Excluding Extraordinary Items -0.82682 -0.72988 -0.57533 -0.40542 -0.30975
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -0.82682 -0.72988 -0.57533 -0.40542 -0.30975
Other, Net 0 0.1224
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0 0 0
Total Operating Expense 2.909 2.40735 2.76335 2.45719 2.68112
Selling/General/Admin. Expenses, Total 0.80874 0.67512 0.68488 0.77925 0.69844
Research & Development 2.10297 1.73223 2.07847 1.67793 1.98268
Operating Income -2.909 -2.40735 -2.76335 -2.45719 -2.68112
Interest Income (Expense), Net Non-Operating 0.01266 0.0077 0.00042 0.00046 0.00053
Net Income Before Taxes -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Net Income After Taxes -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Net Income Before Extra. Items -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Net Income -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Income Available to Common Excl. Extra. Items -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Income Available to Common Incl. Extra. Items -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Diluted Net Income -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
Diluted Weighted Average Shares 12.8795 12.7547 12.6324 12.6044 12.5919
Diluted EPS Excluding Extraordinary Items -0.22488 -0.18814 -0.21872 -0.19491 -0.21288
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.22488 -0.18814 -0.21872 -0.19491 -0.21288
Other Operating Expenses, Total -0.00271
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 20.5216 16.7998 13.2296 7.25222 9.13124
Cash and Short Term Investments 20.3039 16.7371 13.2139 6.89277 8.98189
Cash & Equivalents 20.3039 16.7371 13.2139 6.89277 8.98189
Other Current Assets, Total 0.21775 0.06269 0.01571 0.35945 0.14934
Total Assets 20.5216 16.8687 13.352 7.31796 9.93127
Other Long Term Assets, Total 0 0.06886 0.12238 0.06573 0.80003
Total Current Liabilities 1.58054 1.17667 0.72417 0.39955 0.31187
Payable/Accrued 1.58054 1.17667 0.72417 0.39955 0.31187
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.58054 1.17667 0.72417 0.39955 0.31187
Total Long Term Debt 0 0 0 0 0
Total Equity 18.9411 15.692 12.6279 6.9184 9.6194
Preferred Stock - Non Redeemable, Net
Common Stock 0.0126 0.01145 0.01059 0.00929 0.00929
Additional Paid-In Capital 60.22 47.8736 38.5088 28.5672 28.0379
Other Equity, Total -0.00316 -0.00787 -0.01097 -0.0024 -18.4278
Total Liabilities & Shareholders’ Equity 20.5216 16.8687 13.352 7.31796 9.93127
Total Common Shares Outstanding 12.5981 11.4535 10.6215 10.421 10.421
Retained Earnings (Accumulated Deficit) -41.2884 -32.1852 -25.8806 -21.6557
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 18.0127 20.5216 22.4484 24.3884 25.8377
Cash and Short Term Investments 17.819 20.3039 22.3416 24.2929 25.7231
Cash & Equivalents 17.819 20.3039 22.3416 24.2929 25.7231
Other Current Assets, Total 0.19364 0.21775 0.1068 0.09556 0.11457
Total Assets 18.0664 20.5216 22.5172 24.4573 25.9065
Other Long Term Assets, Total 0 0.06886 0.06886 0.06886
Total Current Liabilities 1.07412 1.58054 1.23994 1.10364 0.80627
Payable/Accrued 1.04815 1.58054 1.23994 1.10364 0.80627
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.09946 1.58054 1.23994 1.10364 0.80627
Total Long Term Debt 0 0 0 0 0
Total Equity 16.9669 18.9411 21.2773 23.3536 25.1003
Common Stock 0.01262 0.0126 0.01259 0.01258 0.01257
Additional Paid-In Capital 60.7031 60.22 59.8776 59.4955 59.162
Retained Earnings (Accumulated Deficit) -43.7451 -41.2884 -38.6078 -36.1493 -34.0692
Other Equity, Total -0.00374 -0.00316 -0.00515 -0.00516 -0.0051
Total Liabilities & Shareholders’ Equity 18.0664 20.5216 22.5172 24.4573 25.9065
Total Common Shares Outstanding 12.6206 12.5981 12.5906 12.5827 12.5699
Property/Plant/Equipment, Total - Net 0.05369
Accrued Expenses 0.02598
Other Liabilities, Total 0.02534
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -9.10322 -6.30457 -4.22487 -3.22793 -16.5549
Cash From Operating Activities -7.3174 -4.66227 -3.01768 -2.68049 -2.62747
Non-Cash Items 1.46805 1.19849 1.01117 0.52933 13.8068
Changes in Working Capital 0.31777 0.44381 0.19602 0.01811 0.12058
Cash From Financing Activities 10.8795 8.18212 9.34741 -0.20627 9.53639
Financing Cash Flow Items -0.06325 -0.11557 -0.98481 -0.20627 4.83074
Issuance (Retirement) of Stock, Net 10.9428 8.17529 10.3322 0 4.70565
Net Change in Cash 3.56676 3.52318 6.32116 -2.88915 6.90892
Foreign Exchange Effects 0.00462 0.00333 -0.00857 -0.0024
Cash Taxes Paid 0 -0.0111
Issuance (Retirement) of Debt, Net 0.1224
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -2.45672 -9.10322 -6.42263 -3.96419 -1.88402
Cash From Operating Activities -2.4675 -7.3174 -5.2855 -3.34418 -1.93806
Non-Cash Items 0.49981 1.46805 1.11789 0.72583 0.36823
Changes in Working Capital -0.51059 0.31777 0.01925 -0.10582 -0.42227
Cash From Financing Activities -0.01667 10.8795 10.8873 10.8973 10.9213
Financing Cash Flow Items -0.01667 -0.06325 -0.05548 -0.0455 -0.0215
Issuance (Retirement) of Stock, Net 0 10.9428 10.9428 10.9428 10.9428
Foreign Exchange Effects -0.00066 0.00462 0.00264 0.00263 0.00277
Net Change in Cash -2.48483 3.56676 5.60446 7.55574 8.986
Issuance (Retirement) of Debt, Net 0 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Tacticgem LLC Corporation 31.1621 4111273 0 2022-04-15 LOW
Gem Pharmaceuticals LLC Corporation 23.1589 3055394 0 2022-04-15 LOW
Hendricks (Diane) Individual Investor 3.553 468750 0 2022-04-15 LOW
Brown Michael J Individual Investor 1.711 225730 2859 2022-12-31 LOW
Tactic Pharma LLC Corporation 1.2633 166667 0 2022-04-15 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.7578 99976 97 2022-12-31 LOW
Robinson (Chandler D) Individual Investor 0.5816 76730 4396 2023-01-01 LOW
Starr (Christopher M) Individual Investor 0.4937 65130 2859 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3175 41892 2721 2022-12-31 LOW
Cittadine (Andrew) Individual Investor 0.2038 26894 2656 2022-12-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1735 22884 -293 2022-12-31 LOW
Mazar (Andrew Paul) Individual Investor 0.1677 22125 0 2022-04-15 LOW
Klausner (Arthur J) Individual Investor 0.1571 20730 2859 2022-12-31 LOW
Tsuchimoto (Kim R) Individual Investor 0.1403 18507 728 2023-01-01 MED
Anderson (Raymond William) Individual Investor 0.1268 16730 2859 2022-12-31 MED
Northern Trust Global Investments Investment Advisor 0.1 13197 0 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.0303 4000 0 2022-12-31 LOW
UBS Financial Services, Inc. Investment Advisor 0.0239 3154 -2245 2022-12-31 LOW
Tower Research Capital LLC Hedge Fund 0.0215 2831 -300 2022-12-31 HIGH
Paragon Wealth Strategies, LLC Investment Advisor 0.0004 58 0 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Biotechnology & Medical Research (NEC)

1000 Skokie Blvd Ste 350
WILMETTE
ILLINOIS 60091-1146
US

Income Statement

  • Annual
  • Quarterly

People also watch

Gold

1,980.12 Price
-0.010% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short 0.0098%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Oil - Crude

74.89 Price
+0.700% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0049%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

BTC/USD

27,949.55 Price
-0.650% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

US100

12,957.30 Price
-0.100% 1D Chg, %
Biaya inap posisi Long -0.0249%
Biaya inap posisi short 0.0027%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda